Randomised controlled study of an intense short course of optimised combination therapy versus conventional therapy for the management of Gram-negative bacteraemia (2014–2018)
Grant type:
Merck Sharp & Dohme Australia Grant for Pharmacotherapeutics in Infectious Diseases